ARCHIVES

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

In Brief: Senate Committee Cuts House Amount For NCI; NCI Staff Faces Up to 22 Days Unpaid Leave

September 21, 1990

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980